作者
Uwe Zeymer, Peter Ludman, Nicolas Danchin, Petr Kala, Cecile Laroche, Masoumeh Sadeghi, Roberto Caporale, Sameh Mohamed Shaheen, Jacek Legutko, Zaza Iakobsishvili, Khalid F Alhabib, Zuzana Motovska, Martin Studencan, Jorge Mimoso, David Becker, Dimitrios Alexopoulos, Zviad Kereseselidze, Sinisa Stojkovic, Parounak Zelveian, Artan Goda, Erkin Mirrakhimov, Gani Bajraktari, Hasan Al-Farhan, Pranas Šerpytis, Bent Raungaard, Toomas Marandi, Alice May Moore, Martin Quinn, Pasi Paavo Karjalainen, Gabriel Tatu-Chitolu, Chris P Gale, Aldo P Maggioni, Franz Weidinger
发表日期
2021/11/21
期刊
European heart journal
卷号
42
期号
44
页码范围
4536-4549
出版商
Oxford University Press
简介
Aims
The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI).
Methods and results
Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24 h in 196 centres across 29 countries. A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0–100%), fibrinolysis (18.8%; 0–100%), and no reperfusion therapy (9.0%; 0–75%) were performed. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.5–5.9 …
学术搜索中的文章
U Zeymer, P Ludman, N Danchin, P Kala, C Laroche… - European heart journal, 2021